References
- Lughezzani G, Burger M, Margulis V, et al. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol. 2012;62(1):100–114.
- Roscigno M, Brausi M, Heidenreich A, et al. Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer. Eur Urol. 2011;60(4):776–783.
- Roscigno M, Shariat SF, Margulis V, et al. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol. 2009;181(6):2482–2489.
- Lughezzani G, Jeldres C, Isbarn H, et al. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology. 2010;75(1):118–124.
- Kondo T, Tanabe K. Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract. Int J Urol [Internet]. 2012; 19(8):710–721. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22515472
- Kondo T, Nakazawa H, Ito F, et al., Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract. J. Urol. 2007;178(4Pt 1):1212–1217; discussion 1217
- Brausi MA, Gavioli M, De Luca G, et al. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival. Eur Urol. 2007;52(5):1414–1420.
- Roscigno M, Cozzarini C, Bertini R, et al. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. Eur Urol. 2008;53(4):794–802.
- Roscigno M, Shariat SF, Margulis V, et al. The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur Urol. 2009;56(3):512–519.
- Kondo T, Hashimoto Y, Kobayashi H, et al. Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: impact on patient survival. Int J Urol [Internet]. 2010;17:848–854. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20812922
- Abe T, Shinohara N, Muranaka M, et al. Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: multi-institutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes. Eur J Surg Oncol. 2010;36(11):1085–1091.
- Abe T, Takada N, Matsumoto R, et al. Outcome of regional lymphadenectomy in accordance with primary tumor location on laparoscopic nephroureterectomy for urothelial carcinoma of the upper urinary tract: a prospective study. J Endourol [Internet]. 2015;29:304–309. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25255401
- Kondo T, Hara I, Takagi T, et al. Possible role of template-based lymphadenectomy in reducing the risk of regional node recurrence after nephroureterectomy in patients with renal pelvic cancer. Jpn J Clin Oncol [Internet]. 2014;44:1233–1238. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25271269
- Roupret M, Babjuk M, Comperat E, et al. European association of urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update. Eur. Urol. 2015;68(5):868–879
- Stein JP, Skinner DG. The role of lymphadenectomy in high-grade invasive bladder cancer. Urol Clin North Am. 2005;32(2):187–197.
- Herr HW, Bochner BH, Dalbagni G, et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol. 2002;167(3):1295–1298.
- Mason RJ, Kassouf W, Bell DG, et al. The contemporary role of lymph node dissection during nephroureterectomy in the management of upper urinary tract urothelial carcinoma: the Canadian experience. Urology. 2012;79(4):840–845.
- Russo P. Editorial comment. Urology. 2009;74(5):1075–1076.
- Mandalapu RS, Remzi M, De Reijke TM, et al. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma. World J. Urol [Internet]. 2016. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27233780
- Seisen T, Shariat SF, Cussenot O, et al. Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma. World J. Urol [Internet]. 2016. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26809456
- Seisen T, Nison L, Remzi M, et al. Oncologic outcomes of kidney sparing surgery versus radical nephroureterectomy for the elective treatment of clinically organ confined upper tract urothelial carcinoma of the distal ureter. J Urol. 2016;195(5):1354–1361
- Moher D, Liberati A, Tetzlaff J, et al. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Plos Med [Internet]. 2009;6(7):e1000097. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19621072
- Komatsu H, Tanabe N, Kubodera S, et al. The role of lymphadenectomy in the treatment of transitional cell carcinoma of the upper urinary tract. J Urol. 1997;157(5):1622–1624.
- Kondo T, Nakazawa H, Ito F, et al., Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract. Urology. 2007;69(2):265–269.
- Matin SF, Sfakianos JP, Espiritu PN, et al., Patterns of lymphatic metastases in upper tract urothelial carcinoma and proposed dissection templates. J Urol. 2015;194(6):1567–1574.
- Secin FP, Koppie TM, Salamanca JIM, et al. Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer. Int. J. Urol [Internet]. 2007;14:26–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17199856
- Busby JE, Brown GA, Matin SF. Comparing lymphadenectomy during radical nephroureterectomy: open versus laparoscopic. Urology. 2008;71(3):413–416.
- Rao SR, Correa JJ, Sexton WJ, et al. Prospective clinical trial of the feasibility and safety of modified retroperitoneal lymph node dissection at time of nephroureterectomy for upper tract urothelial carcinoma. BJU Int [Internet]. 2012;110:E475–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22564727
- Miyake H, Hara I, Gohji K, et al. The significance of lymphadenectomy in transitional cell carcinoma of the upper urinary tract. Br J Urol [Internet]. 1998; 82(4):494–498. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9806176
- Bolenz C, Shariat SF, Fernández MI, et al. Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density. BJU Int [Internet]. 2009;103:302–306. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18990164
- Kondo T, Hara I, Takagi T, et al. Template-based lymphadenectomy in urothelial carcinoma of the renal pelvis: a prospective study. Int J Urol [Internet]. 2014;21:453–459. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24754341
- Batata MA, Whitmore WF, Hilaris BS, et al. Primary carcinoma of the ureter: a prognostic study. Cancer [Internet]. 1975; 35(6):1626–1632. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1148996
- Green DA, Rink M, Xylinas E, et al. Urothelial carcinoma of the bladder and the upper tract: disparate twins. J Urol. 2013;189(4):1214–1221.
- Koppie TM, Vickers AJ, Vora K, et al. Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Cancer [Internet]. 2006; 107(10):2368–2374. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17041887
- Kassouf W, Svatek RS, Shariat SF, et al. Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder. Urol. Oncol. 2013;31(4):480–486.
- Karl A, Carroll PR, Gschwend JE, et al. The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol. 2009;55(4):826–835.
- Tilki D, Brausi M, Colombo R, et al. Lymphadenectomy for bladder cancer at the time of radical cystectomy. Eur Urol. 2013;64(2):266–276.
- Bruins HM, Veskimae E, Hernandez V, et al. The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review. Eur Urol. 2014;66(3):489–499.
- Fransen Van De Putte EE, Hermans TJN, Werkhoven EV, et al. Lymph node count at radical cystectomy does not influence long-term survival if surgeons adhere to a standardized template. Urol. Oncol. 2015;33(12):504.e19-24.
- Kondo T, Takagi T, Tanabe K. Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract. World J Clin Oncol [Internet]. 2015; 6(6):237–251. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26677437
- Pohar KS. The anatomic extent and completeness of pelvic lymphadenectomy is what matters. Curr Opin Urol [Internet]. 2013; 23(5):444–448. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23851384
- Akaza H, Koiso K, Niijima T. Clinical evaluation of urothelial tumors of the renal pelvis and ureter based on a new classification system. Cancer [Internet]. 1987; 59(7):1369–1375. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3815309
- Briganti A, Giannarini G, Karnes RJ, et al. What evidence do we need to support the use of extended pelvic lymph node dissection in prostate cancer? Eur Urol. 2015 Apr;67(4):597–598.